Leukemia, Lymphoid: all 1,772 studies
Page 9 of 18. Open to participants first (173), then studies with results posted, then the rest; newest registration first within each.
- Ponatinib in Adult Ph+ ALL Patients With MRD Positivity or Hematological RelapseActive, not recruitingNCT04475731Phase 2
- Healthy Bones, Healthy Life: Habitual Physical Activity on Bone & Metabolic Health in Pediatric Cancer SurvivorsCompletedNCT04472286
- HA-1H TCR T Cell for Relapsed/Persistent Hematologic Malignancies After Allogeneic Stem Cell TransplantationWithdrawnNCT04464889Phase 1
- Blincyto Amgen Acrotech BioPharma PH2 Blincyto Marqibo R/R Philadelphi CD19+ ALLWithdrawnNCT04448834Phase 2
- Preclinical Project on the Traitment of Acute Lymphoblastique Leukemia With NVP-BEP800, an Inhibitor of the Heat Shock Protein HSP90Status unknownNCT04437420
- A Safety and Preliminary Efficacy Study of CC-99282 in Combination With Obinutuzumab in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaCompletedNCT04434196Phase 1
- Observatory of Patients With Chronic Lymphocytic Leukemia / Lymphocytic Lymphoma or Waldenstrom Disease Infected With COVID-19CompletedNCT04391946
- Correlation of Polymorphisms of Lipoprotein Lipase (LpL) and Apolipoprotein E (Apo E) With Lipid Profile of Children With Acute Lymphoblastic Eukaemia During Therapy With L - Asparaginase.Status unknownNCT04364451
- Observational Trial of Real-World Treatment Utilization and Effectiveness of PI3K-inhibitors in CLL/SLL and FLTerminatedNCT04342117
- Study of Anti-CD22 CAR-T Cells Treating Leukemia ChildrenCompletedNCT04340167Phase 2
- Phase II Study of Anti-CD19 CAR-T Cells Treating Leukemia ChildrenCompletedNCT04325841Phase 2
- TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic LeukemiaCompletedNCT04323657Phase 1/2
- Continuous Ambulatory Monitoring to Predict Elevated Risk of Infection in Children With Lymphoblastic Leukemia Undergoing Induction Chemotherapy (CAMPER-ALL)WithdrawnNCT04322084
- Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's LymphomasTerminatedNCT04305444Phase 2
- Determination of Blood Tumor CellsCompletedNCT04290923
- Anti-CD19 CAR in PiggyBac Transposon-Engineered T Cells for Relapsed/Refractory B-cell Lymphoma or B-cell Acute Lymphoblastic LeukemiaStatus unknownNCT04289220Phase 1
- Safety and Efficacy of CD19-Targeted CAR-T Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and LymphomaStatus unknownNCT04271800Phase 1/2
- FT596 as a Monotherapy and in Combination With Anti-CD20 Monoclonal AntibodiesTerminatedNCT04245722Phase 1
- Matched Unrelated vs. Haploidentical Donor for Allogeneic Stem Cell Transplantation in Patients With Acute LeukemiaActive, not recruitingNCT04232241Phase 2
- A Clinical Trial of CNCT19 Cells in the Treatment of CD19 Positive Relapsed or Refractory Acute Lymphoblastic LeukemiaCompletedNCT04230473Phase 1
- The Individualized Treatment of 6-mercaptopurine in Children With Acute Lymphoblastic Leukemia in ChinaStatus unknownNCT04228393Phase 2/3
- CCCG Relapsed Acute Lymphoblastic Leukemia 2017 Study in ChildrenCompletedNCT04224571Phase 2
- Dietary Intervention With High Phenolic EVOO in CLLCompletedNCT04215367Not applicable
- Study of CD19 Specific Chimeric Antigen Receptor Positive T Cells (CAR-T) in ALL and NHLStatus unknownNCT04206943Phase 1/2
- A Clinical Study of CAR-T Cells Treatment for Children With CD19+/CD22+ R/R ALL and LymphomaStatus unknownNCT04204161Phase 1
- Evaluation of Therapeutic Video Games for Pre-school Children With Acute Lymphoblastic LeukemiaCompletedNCT04199637Not applicable
- A Study of the Safety and Efficacy of Venetoclax in Japanese Participants With Relapsed and Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Leukemia)CompletedNCT04198415
- The Association Between Asparaginase Enzyme Activity Levels and Toxicities in Childhood Acute Lymphoblastic Leukaemia in NOPHOALL 2008CompletedNCT04187248
- Study to Investigate the Use of Acalabrutinib in the Treatment of Patients With Chronic Lymphocytic LeukemiaCompletedNCT04178798Phase 3
- The Clinical Study of CD19 UCAR-T Cells in Patients With B-cell Acute Lymphoblastic Leukemia (B-ALL)Status unknownNCT04166838Early Phase 1
- Study of Tisagenlecleucel in Chinese Pediatric and Young Adult Subjects With Relapsed or Refractory B-cell ALLWithdrawnNCT04156659Phase 2
- CTA101 UCAR-T Cell Injection for Treatment of Relapsed or Refractory CD19+ B-cell Acute Lymphoblastic LeukemiaStatus unknownNCT04154709Phase 1
- Transcranial Direct Current Stimulation of the Temporal Cortex in Survivors of Childhood Acute Lymphoblastic Leukemia (ALL)Active, not recruitingNCT04105530Not applicable
- Effect of Vitamin D Diffiency on Oral Mucosa in Patients Recieving Methotrexate ChemotherapyStatus unknownNCT04096846
- Safety and Efficacy of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy in R/R Acute B Lymphoblastic LeukemiaWithdrawnNCT04094766Phase 1
- Observational Study of CLL/SLL Treatment and Ibrutinib Treatment of CLL/SLL in Routine Clinical PracticeStatus unknownNCT04094051
- FoxO3a and PU.1 in Acute Lymphoblastic LeukemiaStatus unknownNCT04092348
- A Prospective Cohort of Obinutuzumab and Chlorambucil (GC) Chemotherapy for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia Including Next- Generation Sequencing (NGS)-Based AssessmentStatus unknownNCT04059081Phase 2
- Blinatumomab for MRD in Pre-B ALL Patients Following Stem Cell TransplantTerminatedNCT04044560Phase 2
- ERK 1/2 Signaling in Ibrutinib Resistant B-cell MalignanciesWithdrawnNCT04043845Phase 1
- CRISPR (HPK1) Edited CD19-specific CAR-T Cells (XYF19 CAR-T Cells) for CD19+ Leukemia or Lymphoma.Status unknownNCT04037566Phase 1
- CD19-CD22 Chimeric Antigen Receptor T (CAR-T) Cell for Treatment of B Cell Acute Lymphoblastic Leukemia (B-ALL)TerminatedNCT04034446Early Phase 1
- Modified Immune Cells (CD19-CD22 CAR T Cells) in Treating Patients With Recurrent or Refractory CD19 Positive, CD22 Positive Leukemia or LymphomaWithdrawnNCT04029038Phase 1/2
- A Study to Evaluate Impact of Ibrutinib on the Quality of Life (QOL) in Patients With Chronic Lymphocytic LeukemiaCompletedNCT04016636
- Effects of Exercises on Total Body Health in Children With Acute Lymphoblastic LeukemiaCompletedNCT04015882Not applicable
- Study Evaluating the Efficacy and Safety With CD19CAR-T for Relapsed or Refractory Acute Lymphoblastic LeukemiaStatus unknownNCT04012879Phase 1
- CD7 CAR-T Cells for Patients With R/R CD7+ NK/T Cell Lymphoma,T-lymphoblastic Lymphoma and Acute Lymphocytic LeukemiaStatus unknownNCT04004637Phase 1
- Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic LeukemiaCompletedNCT03991884Phase 1
- Health Care Utilisation Among Survivors of Childhood Acute Lymphoblastic LeukaemiaCompletedNCT03985826
- The Value of Follow-Up After Childhood Acute Lymphoblastic Leukaemia in Denmark - Family PerspectivesWithdrawnNCT03985215
- Allogeneic Donor Lymphocyte Infusions Combined With BlinatumomabWithdrawnNCT03982992Phase 2
- Irradiation-based Myeloablative Conditioning Followed by Treg/Tcon Immunotherapy in HSCTStatus unknownNCT03977103Phase 2
- Evaluation of the Redox Profiles of Healthy and Pathological B Cells in Patients With Chronic Lymphocytic LeukemiaStatus unknownNCT03971565
- Reduced IV Fluids to Improve Clearance of HDMTX in Children w/Lymphoma or Acute Lymphoblastic LeukemiaCompletedNCT03964259Phase 1
- Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Patients With Relapsed/Refractory B-cell ALLActive, not recruitingNCT03962465Phase 1
- Ibrutinib and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia After Ibrutinib ResistanceWithdrawnNCT03943342Phase 2
- Peptide Vaccination With PD-L1 and PD-L2 Peptides in Untreated Chronic Lymphatic Leukemia.CompletedNCT03939234Phase 2
- Determinants of Mercaptopurine Toxicity in Paediatric Acute Lymphoblastic Leukemia Maintenance TherapyStatus unknownNCT03920813Phase 4
- Anti-CD19/CD22 Bispecific Chimeric Antigen Receptor（CAR)-T Cell Therapy for Measurable Residual Disease(MRD) Positive ALLCompletedNCT03919526Phase 1
- A Study of JNJ-67856633 in Participants With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)CompletedNCT03900598Phase 1
- Duvelisib and Nivolumab in Treating Patients With Richter Syndrome or Transformed Follicular LymphomaCompletedNCT03892044Phase 1
- Intravenous Ixazomib in Pediatric Participants With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LLy)WithdrawnNCT03888534Phase 1
- Trabectedin and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Resistant or Intolerant to a BTK InhibitorWithdrawnNCT03884972Phase 1
- Real-World Data Study Focused on Chronic Lymphocytic Leukemia (CLL) Patient Treatment Options and Their EffectivenessStatus unknownNCT03881592
- Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialTerminatedNCT03878524Phase 1
- A Study to Assess Effectiveness of Venclexta (Venetoclax) in Patients With Relapse or Refractory Chronic Lymphocytic Leukemia in Routine Clinical Practice in Russian FederationCompletedNCT03873857
- Assessment of Financial Difficulty in Participants with Chronic Lymphocytic Leukemia and Multiple MyelomaCompletedNCT03870633
- Ex Vivo Drug Sensitivity Testing and Mutation ProfilingCompletedNCT03860376
- CD19 CAR-T Cell Therapy for Relapsed/Refractory B-cell Lymphoma and B-cell Acute Lymphoblastic LeukemiaStatus unknownNCT03854994Phase 1
- Inotuzumab Ozogamicin and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic LeukemiaWithdrawnNCT03851081Phase 1/2
- Bendamustine and Rituximab (BR) as Induction and Maintenance in Relapsed and Refractory Chronic Lymphocytic LeukemiaStatus unknownNCT03847727
- Senl_1904A and Senl_1904B Chimeric Antigen Receptor （CAR） T-Cell in the Treatment of r/ r Acute B Lymphocytic LeukemiaStatus unknownNCT03840317Phase 1
- A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Hematologic Malignancies (MK-2140-001)CompletedNCT03833180Phase 1
- Blinatumomab Expanded T-cells (BET) in Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic LeukemiaStatus unknownNCT03823365Phase 1
- SCT in Ph Positive Acute Lymphoblastic LeukemiaCompletedNCT03821727
- The Incidence of Hepatitis B in Diffuse Large B-Cell Lymphoma/Chronic Lymphoid Leukemia HBsAg-positive Treated With Rituximab, Chemotherapy and Tenofovir AlafenamideTerminatedNCT03804372Phase 2
- Clinical Significance of Occult Central Nervous System Disease In Adult Acute Lymphoblastic LeukemiaCompletedNCT03803670
- Human CD19 Targeted T Cells Injection Therapy for Relapsed and Refractory CD19-positive LeukemiaStatus unknownNCT03798509Phase 1
- Sequential Regimen of Bendamustin-Debulking Followed by Obinutuzumab, Acalabrutinib and Venetoclax in Patients with Relapsed/refractory CLLCompletedNCT03787264Phase 2
- Cardiovascular Function in Acute LeukemiaCompletedNCT03760237
- Ibrutinib, Obinutuzumab and Venetoclax for Patients With Chronic Lymphocytic LeukemiaCompletedNCT03755947Phase 2
- Blinatumomab Plus HLA-Mismatched Cellular Therapy for Relapsed/Refractory CD19+ ALLCompletedNCT03751709Phase 1
- REALIB-LLA-2017: Idelalisib in Patients With Acute Lymphoblastic LeukemiaTerminatedNCT03742323Phase 1/2
- Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood CancerWithdrawnNCT03739606Phase 2
- CYC065 CDK Inhibitor and Venetoclax Study in Relapsed/Refractory CLLCompletedNCT03739554Phase 1
- A Study to Evaluate Ibrutinib Retention in Chronic Lymphocytic Leukemia Participants Treated in a Real World SettingCompletedNCT03720561
- Blinatumomab in High-risk B-cell Precursor Acute Lymphoblastic LeukemiaActive, not recruitingNCT03709719Phase 2
- Ibrutinib lead-in Followed by Venetoclax Plus Ibrutinib in Patients With RR CLLTerminatedNCT03708003Phase 2
- International Trial of Selumetinib in Combination With Dexamethasone for the Treatment of Acute Lymphoblastic LeukaemiaTerminatedNCT03705507Phase 1/2
- CART19 Cells Treatment of MRD of B Cell Malignancies and Then Auto-HSCTStatus unknownNCT03685786Phase 1
- CD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-ALL.Status unknownNCT03671460Phase 1
- Asparaginase Activity Monitoring (AAM) in Adult Patients With Acute Lymphoblastic Leukemia (ALL)TerminatedNCT03668392Phase 2
- The Impact of Exercise Approaches on Sleep in Children With Acute Lymphoblastic LeukemiaCompletedNCT03664947Not applicable
- A Study to Describe the Effectiveness and Safety of Venetoclax Treatment in Chronic Lymphocytic Leukemia (CLL) Patients in Routine Clinical PracticeSuspendedNCT03659669
- CALLS: CML and Ph+ALL Low Level Mutation Prevalence SurveyCompletedNCT03647215
- Rituximab, Idelalisib, and Venetoclax in Relapsed/Refractory CLL/SLLWithdrawnNCT03639324Phase 1
- Observational Study of Ibrutinib Use in CLLStatus unknownNCT03633045
- Tisagenlecleucel vs Blinatumomab or Inotuzumab for Patients With Relapsed/Refractory B-cell Precursor Acute Lymphoblastic LeukemiaWithdrawnNCT03628053Phase 3
- Immunotherapy With CD19 CART-cells for B Cell Acute Lymphoblastic LeukemiaStatus unknownNCT03599375Phase 1
- Evaluate the Neuroprotective Effect of Vitamin B6 and Vitamin B12 Against Vincristine Induced Neurotoxicity in Acute Lymphoblastic Leukaemia PatientsCompletedNCT03593304Phase 2/3